Our findings are consistent with studies in mouse laminopathy models in which rapamycin and temsirolimus had beneficial effects on heart and skeletal muscle through inhibition of AKT/mTOR signaling (Choi et al., 2012; Ramos et al., 2012). The gene discussed is AKT1; the disease is laminopathy.